文献速递痛风与晶体性关节病

利用数据驱动方法对使用降尿酸治疗的痛风患者医疗支出进行分类与预测

Using Data-Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate-Lowering Therapy.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-01-18

该研究基于2017—2019年保险理赔数据,采用基于组的轨迹模型对57,980例40岁及以上接受降尿酸治疗的痛风患者按2年总医疗支出分类,并评估预测各支出组归属的能力。最佳拟合模型分为低支出组(13.2%)、中等支出组(37.4%)和高支出组(49.4%),预测能力总体较高(全预测因子提升C统计量:低支出组0.89、中等支出组0.78、高支出组0.90)。高支出组最具影响力的预测因子为更高的痛风药物依从性和糖尿病诊断。

要点

  • 接受降尿酸治疗的痛风患者可分为低支出(13.2%)、中等支出(37.4%)和高支出(49.4%)三个长期医疗支出轨迹组。
  • 全预测因子模型对各支出组的预测C统计量分别为低支出组0.89、中等支出组0.78、高支出组0.90。
  • 高支出组最具影响力的预测因子为更高的痛风药物依从性和糖尿病诊断。

核心结论

  • 使用降尿酸治疗的痛风患者存在不同的长期医疗支出模式,且数据驱动模型可高精度预测支出组归属。
  • 若干临床预测因子(如痛风药物使用或糖尿病)可能是干预的关键领域。

研究设计与样本

  • 研究使用2017—2019年保险理赔数据,采用基于组的轨迹模型对40岁及以上诊断为痛风并接受降尿酸治疗的患者按2年总医疗支出进行分类。
  • 研究纳入57,980例患者,采用逻辑回归和广义提升回归结合分割样本验证预测各支出组归属,并使用不同预测因子集估计模型、以C统计量评估。

主要发现

  • 在57,980例患者中,平均±标准差年龄为71.0±10.5岁,女性17,194例(29.7%)。
  • 最佳拟合模型包含低支出组(13.2%)、中等支出组(37.4%)和高支出组(49.4%)。
  • 全预测因子提升C统计量为低支出组0.89、中等支出组0.78、高支出组0.90,总体预测能力较高。
  • 高支出组最具影响力的预测因子为更高的痛风药物依从性和糖尿病诊断。

关键数值与推荐

  • 低支出组占13.2%,中等支出组占37.4%,高支出组占49.4%。
  • 全预测因子提升C统计量:低支出组0.89、中等支出组0.78、高支出组0.90。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite increasing overall health care spending over the past several decades, little is known about long-term patterns of spending among US patients with gout. Current approaches to assessing spending typically focus on composite measures or patients agnostic to disease state; in contrast, examining spending using longitudinal measures may better discriminate patients and target interventions to those in need. We used a data-driven approach to classify and predict spending patterns in patients with gout. METHODS: Using insurance claims data from 2017-2019, we used group-based trajectory modeling to classify patients ages 40 years or older diagnosed with gout and treated with urate-lowering therapy (ULT) by their total health care spending over 2 years. We assessed the ability to predict membership in each spending group using logistic and generalized boosted regression with split-sample validation. Models were estimated using different sets of predictors and evaluated using C statistics. RESULTS: In 57,980 patients, the mean ± SD age was 71.0 ± 10.5 years, and 17,194 patients (29.7%) were female. The best-fitting model included the following groups: minimal spending (13.2%), moderate spending (37.4%), and high spending (49.4%). The ability to predict groups was high overall (e.g., boosted C statistics with all predictors: minimal spending [0.89], moderate spending [0.78], and high spending [0.90]). Although average adherence was relatively high in the population, for the high-spending group, the most influential predictors were greater gout medication adherence and diabetes melllitus diagnosis. CONCLUSION: We identified distinct long-term health care spending patterns in patients with gout using ULT with high accuracy. Several clinical predictors could be key areas for intervention, such as gout medication use or diabetes melllitus.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Lauffenburger JC, Lu Z, Mahesri M, et al. Using Data-Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate-Lowering Therapy. Arthritis Care Res (Hoboken). 2023. PMID: 36039962. doi:10.1002/acr.25008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。